Evidence map›Paper›PMID 42758397›Full record

ArticleApplied biochemistry and biotechnology2026

Nuclear Import of E2F1 Regulated by KPNB1 is Essential for Proliferation and Invasion of Cervical Cancer Cells.

Mengjie Zhang, Jing Hai, Jing Yang, Ying Zhang, Xuecai Dong

Abstract read
PubMed Publisher
In one paragraph

Article in Applied biochemistry and biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Mengjie ZhangGynecological Oncology Dept.1, Xinxiang Central Hospital, The Fourth Clinical College of Henan Medical University, Xinxiang, 453000, Henan, China.
Jing HaiGynecological Oncology Dept.1, Xinxiang Central Hospital, The Fourth Clinical College of Henan Medical University, Xinxiang, 453000, Henan, China.
Jing YangGynecological Oncology Dept.1, Xinxiang Central Hospital, The Fourth Clinical College of Henan Medical University, Xinxiang, 453000, Henan, China.
Ying ZhangGynecological Oncology Dept.1, Xinxiang Central Hospital, The Fourth Clinical College of Henan Medical University, Xinxiang, 453000, Henan, China.
Xuecai DongGynecological Oncology Dept.1, Xinxiang Central Hospital, The Fourth Clinical College of Henan Medical University, Xinxiang, 453000, Henan, China. dongxuecai@163.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

As a nuclear transport receptor, KPNB1 transport proteins from cytoplasm into nucleus, performing a vital function in intracellular traffic. The aberrant upregulation of KPNB1 has been associated with various malignancies and transformed cells, where it is indispensable for cellular proliferation and survival. Transcription factors like E2F1 possess a nuclear localization motif that triggers the expression of a range of crucial factors during tumorigenesis. This investigation explores the influence of KPNB1 in cervical cancer (CC) cell metastasis and proliferation through the modulation of E2F1 nuclear import. Overexpression of KPNB1 was consistently detected in cervical carcinoma tissues and associated cell lines, with notably higher levels observed relative to normal cervical mucosa. Functional studies demonstrated that KPNB1 silencing induced a marked attenuation in the invasive, migratory, and proliferative capacities of HeLa and SiHa cells. Furthermore, inhibition of KPNB1 hindered the nuclear translocation of E2F1. Importantly, the application of ARQ171, a small-molecule compound that functionally elevates E2F1 expression, negated partially the suppressive effects of KPNB1 on migration, invasion, and growth of CC cells via elevating the total amount of nuclear E2F1, suggesting that E2F1 mediates the oncogenic role of KPNB1 in CC progression. The research findings highlight the potential utility of targeting KPNB1-E2F1 axis as an innovative treatment modality, underscoring its promise as a novel approach in cervical cancer treatment.

Indexed as

Cervical cancerE2F1KPNB1MetastasisNuclear import

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.